Short answer · Medically reviewed summary · Last updated: 2026-04-07
Pulmonary Fibrosis is a chronic, progressive lung disease characterized by the scarring and thickening of the tissue surrounding the air sacs in the lungs, which makes it increasingly difficult for oxygen to enter the bloodstream. How Pulmonary Fibrosis Affects the Body When you have Pulmonary Fibrosis, the delicate tissue in your lungs becomes damaged and scarred. Over time, this stiffened, scarred tissue makes it harder for your lungs to work properly.
What is Pulmonary Fibrosis
What is Pulmonary Fibrosis? Plain-language, medically reviewed definition plus the lived reality told by patients.
Pulmonary Fibrosis is a chronic, progressive lung disease characterized by the scarring and thickening of the tissue surrounding the air sacs in the lungs, which makes it increasingly difficult for oxygen to enter the bloodstream.
How Pulmonary Fibrosis Affects the Body
When you have Pulmonary Fibrosis, the delicate tissue in your lungs becomes damaged and scarred. Over time, this stiffened, scarred tissue makes it harder for your lungs to work properly. As the disease progresses, the body struggles to transfer oxygen from the air you breathe into the blood, leading to symptoms like shortness of breath, a persistent dry cough, and fatigue.
Classification and Prevalence
While there are over 200 different types of interstitial lung diseases, Pulmonary Fibrosis is often classified into two main categories: known causes (such as environmental exposures or autoimmune conditions) and idiopathic, where the cause is unknown. The most common form of the latter is Idiopathic Pulmonary Fibrosis (IPF). While prevalence varies globally, it is estimated to affect approximately 13 to 20 per 100,000 people worldwide, though these numbers are often higher in older populations.
Who is Affected?
Pulmonary Fibrosis is most commonly diagnosed in adults between the ages of 50 and 70. Historically, it has been identified more frequently in men than in women, though this gap is narrowing. While genetics can play a role in some familial cases, environmental factors, smoking history, and chronic acid reflux are also considered potential contributors to the development of the condition.
Key Distinctions
What differentiates Pulmonary Fibrosis from other respiratory conditions like asthma or COPD is the nature of the damage; while asthma involves reversible airway constriction, this condition involves permanent structural changes to the lung parenchyma (the functional tissue). Unlike inflammatory lung conditions that may respond to steroids, the primary challenge here is the progressive accumulation of scar tissue that does not easily resolve.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Pulmonary Fibrosis
- Orphanet: Idiopathic Pulmonary Fibrosis
- Pulmonary Fibrosis Foundation: Understanding the Disease
